Crystal structure of wild-type human procathepsin K

Protein Science

Volumn 8, Issue 2, 1999, Pages 283-290

  Sivaraman, J ^a,b,c   Lalumière, Manon ^a   Ménard, Robert ^a,b   Cygler, Miroslaw ^a,b,c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b Networks of Centres of Excellence   (Canada)

^c Montreal Jt Ctr for Struct Biol   (Canada)

Author keywords

Crystal structure; Cysteine protease; Procathepsin K; Proregion; Prosegment

Indexed keywords

CATHEPSIN K; CYSTEINE PROTEINASE; ENZYME PRECURSOR; LYSOSOME ENZYME; PAPAIN; PROCATHEPSIN K; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; ENZYME CONFORMATION; ENZYME PURIFICATION; ENZYME SPECIFICITY; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

EID: 0344938353     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.2.283     Document Type: Article

References (28)

1. Bromme D, Okamoto K, Wang BB, Biroc S. 1996. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 271:2126-2132.
2. Brünger AT. 1993. X-Plor Version 3.1. New Haven, CT: Yale University.
3. Carmona E, Dufour E, Plouffe C, Takebe S, Mason P, Mort JS, Menard R. 1996. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry 35:8149-8157.
4. Chapman HA, Riese RJ, Shi GP. 1997. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59:63-88.
5. Coulombe R, Grochulski P, Sivaraman J, Menard R, Mort JS, Cygler M. 1996. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J 15:5492-5503.
6. Cygler M, Mort JS. 1997. Proregion structure of members of the papain superfamily. Mode of inhibition of enzymatic activity. Biochimie 79:645-652.
7. Cygler M, Sivaraman J, Grochulski P, Coulombe R, Storer AC, Mort JS. 1996. Structure of rat procathepsin B: Model for inhibition of cysteine protease activity by the proregion. Structure 4:405-416.
8. Fox T, de Miguel E, Mort JS, Storer AC. 1992. Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry 31:12571-12576.
9. Gelb BD, Shi GP, Chapman HA, Desnick RJ. 1996. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238.
10. Groves MR, Coulombe R, Jenkins J, Cygler M. 1998. Structural basis for specificity of papain like cysteine protease proregions toward their cognate enzymes Proteins Struct Funct Genet 32:504-514.
11. Groves MR, Taylor MAJ, Scott M, Cummings NJ, Pickersgill RW, Jenkins JA. 1996. The prosequence of procaricain forms an alpha-helical domain that prevents access to the substrate-binding cleft. Structure 4:1193-1203.
12. Jones TA, Zhou JY, Cowan SW, Kjeldgaard M. 1991. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr A47:110-119.
13. Karrer KM, Peiffer SL, DiTomas ME. 1993. Two distinct gene subfamilies within the family of cysteine protease genes. Proc Natl Acad Sci USA 90:3063-3067.
14. Kleywegt GJ, Jones TA. 1994. Halloween . . . masks and bones. In: Bailey S, Hubbard R. Waller D, eds. From first map to final model. Warrington, UK: SERC Daresbury Laboratory. pp 59-66.
15. Linnevers CJ, Smeekens SP, Bromme D. 1997. Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes. FEBS Lett 405:253-259.
16. Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA, Bilbe G. 1997. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81-86.
17. Maubach G, Schilling K, Rommerskirch W, Wenz I, Schultz JE, Weber E, Wiederanders B. 1997. The inhibition of cathepsin S by its propeptide -Specificity and mechanism of action. Eur J Biochem 250:745-750.
18. McGrath ME, Klaus JL, Barnes MG, Bromme D. 1997. Crystal structure of human cathepsin K complexed with a potent inhibitor. Nat Struct Biol 4:105-109.
19. McQueney MS, Amegadzie BY, D'Alessio K, Hanning CR, McLaughlin MM, McNulty D, Carr SA, Ijames C, Kurdyla J, Jones CS. 1997. Autocatalytic activation of human cathepsin K. J Biol Chem 272:13955-13960.
20. Navaza J. 1994. AMoRe: An automated package for molecular replacement. Acta Crystallogr A50:157-163.
21. Podobnik M, Kuhelj R, Turk V, Turk D. 1997. Crystal structure of the wild-type human procathepsin B at 2.5 Å resolution reveals the native active site of a papain-like cysteine protease zymogen. J Mol Biol 271:774-788.
22. Santamaria I, Velasco G, Pendas AM, Fueyo A, Lopez-Otin C. 1998. Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location [in process citation]. J Biol Chem 273:6816-16823.
23. Storer AC. 1991. Engineering of proteases and protease inhibition. Curr Opin Biotechnol 2:606-613.
24. Taylor MAJ, Baker KC, Briggs GS, Connerton IF, Cummings NJ, Pratt KA, Revell DF, Freedman RB, Goodenough PW. 1995. Recombinant proregions from papain and papaya proteinase IV-are selective high affinity inhibitors of the mature papaya enzymes. Protein Eng 8:59-62.
25. Thompson SK, Halbert SM, Bossard MJ, Tomaszek TA, Levy MA, Zhao B, Smith WW, Abdel-Meguid SS, Janson CA, D'Alessio KJ, et al. 1997. Design of potent and selective human cathepsin K inhibitors that span the active site. Proc Natl Acad Sci USA 94:14249-14254.
26. Turk D, Podobnik M, Kuhelj R, Dolinar M, Turk V. 1996. Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide. FEBS Lett 384:211-214.
27. Turk B, Turk V, Turk D. 1997. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 378:141-150.
28. Zhao B, Janson CA, Amegadzie BY, D'Alessio K, Griffin C, Hanning CR, Jones C, Kurdyla J, McQueney M, Qiu X. 1997. Crystal structure of human osteoclast cathepsin K complex with E-64. Nat Struct Biol 4:109-111.